Susquehanna International Group’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.3K Buy
8,794
+2,651
+43% +$9.4K ﹤0.01% 12862
2026
Q1
$16.6K Buy
+6,143
New +$62.3K ﹤0.01% 12888
2023
Q1
– Sell
-641
Closed -$22.4K – 12619
2022
Q4
$22.4K Sell
641
-262
-29% -$14.7K ﹤0.01% 11728
2022
Q3
$59K Buy
903
+743
+464% +$52.6K ﹤0.01% 12096
2022
Q2
$12K Buy
+160
New +$10.9K ﹤0.01% 12475
2021
Q4
– Sell
-700
Closed -$136K – 13145
2021
Q3
$162K Sell
700
-3,140
-82% -$883K ﹤0.01% 11724
2021
Q2
$1.46M Buy
+3,840
New +$1.26M ﹤0.01% 6711

Other funds holding CALC

Susquehanna International Group's CALC Position: Q2 2026 in Review

Susquehanna International Group increased its CalciMedica (CALC) stake by 43% in Q2 2026, buying an estimated $9.4K and bringing the position to 8,794 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12862.

Susquehanna International Group first reported a position in CALC in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.46M in Q2 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Susquehanna International Group held 8,794 shares of CalciMedica worth $45.3K as of Q2 2026.
  • Susquehanna International Group bought 2,651 CalciMedica shares in Q2 2026, an estimated $9.4K.
  • CalciMedica made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12862 holding.
  • Susquehanna International Group first reported a position in CalciMedica in Q2 2021 and has held it in 7 quarters since.
  • Susquehanna International Group's CalciMedica position peaked at $1.46M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.